Prescribing Alert Increases Rates of Naloxone, Opioid Co-Prescriptions
Drug Topics
JUNE 13, 2023
The alert was implemented after passage of a state senate bill.
Drug Topics
JUNE 13, 2023
The alert was implemented after passage of a state senate bill.
PharmaVoice
JUNE 13, 2023
Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 13, 2023
What is the state of OTC contraception, what’s next for IUDs, and why are so many transgender people denied care?
STAT
JUNE 13, 2023
CHICAGO — The American Medical Association on Tuesday strongly criticized the body mass index , urging doctors to de-emphasize its use in assessing health and obesity and acknowledging that the measurement has been used for “racist exclusion” and has caused “historical harm.” The AMA, one of the largest medical groups in the U.S., voted to adopt this policy during its annual meeting here.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JUNE 13, 2023
A recent study examined the effects that different work environments can have on adults with asthma.
STAT
JUNE 13, 2023
Adolescents who seek treatment for opioid addiction at an inpatient facility are more likely to be offered horseback riding than given full access to a common, highly effective addiction medication. According to a new research paper, just one out of every eight residential treatment facilities open to patients ages 16 or 17 offers full access to buprenorphine.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JUNE 13, 2023
This article was co-published with The Markup , a nonprofit newsroom that investigates how powerful institutions are using technology to change our society. Sign up for its newsletters here. Websites for mental health crisis resources across the country — which promise anonymity for visitors, many of whom are at a desperate moment in their lives — have been quietly sending sensitive visitor data to Facebook, The Markup has found.
Pharmacy Times
JUNE 13, 2023
Providing this treatment for patients with cancer may be a smoother transition for oncology professionals than they might expect.
Fierce Healthcare
JUNE 13, 2023
Legislators and policymakers have put payments to Medicare Advantage (MA) plans under the microscope, and new analysis highlights why. | Legislators and policymakers have put payments to Medicare Advantage plans under the microscope, and new analysis highlights why.
Pharmacy Times
JUNE 13, 2023
Stormi Gale, PharmD, BCCP, a cardiology pharmacy specialist at Novant Health, discussed the important role of SGLT2 inhibitors in glycemic control.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 13, 2023
Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close. What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtaine
Pharmacy Times
JUNE 13, 2023
Study evaluates the interaction between excessive salt intake and hypertension, cognitive dysfunction, and dementia.
Fierce Healthcare
JUNE 13, 2023
Insurers find themselves in the position of needing to say "yes" or "no" to GLP-1 drugs as more people seek them for weight loss. | Ozempic, estimated to cost about $10,000 a year per person, and other GLP-1 drugs could put significant financial strain on payers as demand grows.
STAT
JUNE 13, 2023
Last year, my father, a Jamaican immigrant with Medicaid insurance, passed away from a heart attack. He was only 63 years old. As he received care, he expressed discomfort with the predominantly white teams handling his case. He believed that both clinicians and non-clinical staff discriminated against him because of his racial and ethnic identity, as well as his public insurance status.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
JUNE 13, 2023
The Affordable Care Act's (ACA's) preventive care mandate remains in effect as a federal appeals court mulls a legal challenge to the requirements. | The Affordable Care Act's preventive care mandate remains in effect as a federal appeals court mulls a legal challenge to the requirements.
Drug Store News
JUNE 13, 2023
Teva will pay the state $1.407 million, and the state will dismiss all of its claims against Teva and its affiliates once payment has been made.
Fierce Healthcare
JUNE 13, 2023
A rural Illinois hospital closure slated for the end of the week has been attributed in part to a multiweek ransomware incident the organization suffered in early 2021, marking what experts say is | St. Margaret's Health leadership listed a costly multiweek system lockout as a primary factor for its decision to close its doors this week, representing a new milestone for cyberattacks against healthcare organizations.
STAT
JUNE 13, 2023
After a bitter dispute, the ALS Association has settled a lawsuit filed by 15 chapters that chafed at managerial moves by the national organization and will now break away to form an alternative organization for patients and their families combating the debilitating disease. The details of the settlement have not yet been disclosed, but in a statement, the ALS Association confirmed that a deal was reached that “allows for separation of the… chapters that desire to operate independe
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
JUNE 13, 2023
A new therapeutic radionuclide facility, the world’s largest production site of lutetium-177, has opened in Germany. ITM Isotope Technologies Munich SE ( ITM )’s manufacturing plant in Neufahrn near Munich will produce the innovative medical isotope for targeted cancer therapies. “Radiopharmaceuticals are an essential new class of anti-cancer drugs that have the potential to improve therapy outcomes and quality of life for many patients.
Fierce Pharma
JUNE 13, 2023
Biogen has taken a step to “significantly refresh” its board of directors, departing chair Stelios Papadopoulos, Ph.D., said. | Biogen has taken a step to “significantly refresh” its board of directors, departing chair Stelios Papadopoulos, Ph.D., said. But the reported romantic relationship between a new nominee and a departing member raises questions about one appointment.
European Pharmaceutical Review
JUNE 13, 2023
If approved, VLA1553 could become the first licensed chikungunya vaccine” A single vaccination of VLA1553 has been shown to produce neutralising antibody levels, thought to protect against chikungunya disease in 99 percent of Phase III trial participants. The chikungunya vaccine candidate is the only one globally for which regulatory review processes are underway.
Drug Store News
JUNE 13, 2023
Bubble’s new mineral SPF 40 products include Plus One, a tinted sunscreen, and Solar Mate, an invisible sunscreen.
STAT
JUNE 13, 2023
WASHINGTON — A key House Republican ramped up his criticism of pharmacy benefit managers Tuesday, calling for the government to dismantle companies that have consolidated drug supply chain operations. “We should break these PBMs up,” House Oversight Committee Chair James Comer (R-Ky.) said during an Education and Workforce Committee hearing.
Fierce Healthcare
JUNE 13, 2023
Majority of senior health system execs say nursing shortage is critical, poll finds. What are they doing to address it?
STAT
JUNE 13, 2023
This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board. Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company.
Pharmaceutical Technology
JUNE 13, 2023
Beacon Therapeutics has kickstarted its entry into the gene therapy field with a $120m Series A financing. The British investment trust Syncona Limited launched the new ophthalmic gene therapy company by combining Applied Genetic Technologies Corporation’s (AGTC’s) late-stage X-linked retinitis pigmentosa (XLRP) programme with two proprietary preclinical programmes.
STAT
JUNE 13, 2023
Margaret Gamble was supposed to receive a blood test in the mail in May. It’s a regularly scheduled test to check if her kidney — the second she’s received in a transplant — has been damaged in any way. Her kidney needs to be constantly monitored since it’s vulnerable to infections or, critically, rejection by her immune system.
pharmaphorum
JUNE 13, 2023
Class II approval revs up Huma’s SaMD platform Phil.
STAT
JUNE 13, 2023
Health systems across the country are exploring blending artificial intelligence into their communication with patients, from billing to after-hours messages about medication or symptoms. But how best to actually talk to patients about the technology and its risks is still an open question. STAT asked six health system leaders how they are disclosing their use of AI to the patients the technology is supposed to benefit.
Fierce Healthcare
JUNE 13, 2023
Dogs are our best friends. So how can we help them live longer? Biotech founder Celine Halioua is working on drugs to expand dogs' longevity. | 'Podnosis': Are canines the secret to anti-aging meds and the benefits and challenges of direct contracting and purchase alliances.
STAT
JUNE 13, 2023
Top of the morning to you, and a fine one it is. Sunny skies and cool breezes are enveloping the Pharmalot campus, where the official mascots are snoozing in their respective corners and the short person is sleeping in. As for us, we are going about the usual routine at this time of day — brewing cups of stimulation. Our choice is, once again, roasted coconut.
Drug Store News
JUNE 13, 2023
Whether driven by TikTok or dermatologists’ recommendations, consumers are on the hunt for buzzy ingredients in bath and skin care products.
STAT
JUNE 13, 2023
FRANKFURT, Germany — Protagonist Therapeutics has run into some speed bumps as it’s developed its medicine for a rare blood cancer characterized by the overproduction of red blood cells. In 2021, the Food and Drug Administration put studies of the drug, rusfertide, on hold after a mouse study raised concerns about skin malignancies (the hold was lifted quickly , after less than a month).
Let's personalize your content